---
category: news
title: "AI-driven biomarker predicts optimum length of treatment for prostate cancer"
excerpt: "A biomarker developed with digitalized pathology and artificial intelligence demonstrated it was able to identify which men treated with radiation for high-risk localized prostate cancer could be spared long-term hormone therapy and its potential side effects."
publishedDateTime: 2023-06-02T15:08:00Z
originalUrl: "https://medicalxpress.com/news/2023-06-ai-driven-biomarker-optimum-length-treatment.html"
webUrl: "https://medicalxpress.com/news/2023-06-ai-driven-biomarker-optimum-length-treatment.html"
ampWebUrl: "https://medicalxpress.com/news/2023-06-ai-driven-biomarker-optimum-length-treatment.amp"
cdnAmpWebUrl: "https://medicalxpress-com.cdn.ampproject.org/c/s/medicalxpress.com/news/2023-06-ai-driven-biomarker-optimum-length-treatment.amp"
type: article
quality: 56
heat: 66
published: false

provider:
  name: Medical Xpress
  domain: medicalxpress.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://scx2.b-cdn.net/gfx/news/hires/2019/4-prostatecanc.jpg"
    width: 1920
    height: 1280
    isCached: true

related:
  - title: "ArteraAI Presents New Data Validating AI-Derived Predictive Biomarker at 2023 ASCO Annual Meeting"
    excerpt: "ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announces new data validating a multimodal AI-derived predictive biomarker, which has been selected as an oral presentation at the 2023 ASCO annual meeting."
    publishedDateTime: 2023-06-01T13:01:00Z
    webUrl: "https://www.joplinglobe.com/region/national_business/arteraai-presents-new-data-validating-ai-derived-predictive-biomarker-at-2023-asco-annual-meeting/article_1d4033b9-b457-503b-904b-003d97c6b125.html"
    type: article
    provider:
      name: Joplin Globe
      domain: joplinglobe.com
    quality: 6

secured: "AWefNv4scd46y9q3h2S1YI8fPy2ATAqFuA7BV2kXG93XBcvpo/3Ku2bFmKDmVSY810c3IqQJKfhYBYhv1hmBdmP7msmFSZ9mlqmBkavA8eRwy/+WuG/19w/E74I88WD5R1VMP1COloa+uc7EYm+Y6iw14t/5g/5HLrzjurClsbGq/dQJ22xiBwi1W1Bez/2FGVeuscaMnkhx6thuQXapRc8jbslHQPiH+V4b2+AO3Gj1BPBYyZCSdIFgebqhWWGDxiEzevZL25QPXdEKxnweJ0ZIEPjO/dyt4wmYVZLbs1RP8pZvnBdBTtMlHNxsVBBXQWlyGlrB/JeBvW7GGIlUjJndZjBv8zmn9Omv8oJBso6SqW5OUvoBtqsmlKu++fzOhmoNrnofNfnriU3Ud7IpxfRZMcMrO7ZHffoJF2pFK4zQKgDAquQsU4j2G/gPqn8+Vq6gk9yalVXCKJgK6ICbfnvUPQJBEZ5kxRzeG49bPGHqPU5zYWxNEztyxWivF3MpWevtJi8SzsslfIt/6Gb5vA==;C0Vsz/NlKXcmYa5v+ZdamA=="
---

